- Home
- TPST vs AIXI Comparison
TPST vs AIXI Comparison
Compare TPST & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- AIXI
- Stock Information
- Founded
- TPST 2011
- AIXI 2001
- Country
- TPST United States
- AIXI China
- Employees
- TPST N/A
- AIXI N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- AIXI Computer Software: Prepackaged Software
- Sector
- TPST Health Care
- AIXI Technology
- Exchange
- TPST Nasdaq
- AIXI Nasdaq
- Market Cap
- TPST 33.0M
- AIXI 31.2M
- IPO Year
- TPST N/A
- AIXI 2023
- Fundamental
- Price
- TPST $10.93
- AIXI $1.59
- Analyst Decision
- TPST Hold
- AIXI
- Analyst Count
- TPST 3
- AIXI 0
- Target Price
- TPST $30.00
- AIXI N/A
- AVG Volume (30 Days)
- TPST 83.5K
- AIXI 198.5K
- Earning Date
- TPST 08-11-2025
- AIXI 10-27-2025
- Dividend Yield
- TPST N/A
- AIXI N/A
- EPS Growth
- TPST N/A
- AIXI N/A
- EPS
- TPST N/A
- AIXI N/A
- Revenue
- TPST N/A
- AIXI $70,314,315.00
- Revenue This Year
- TPST N/A
- AIXI $26.84
- Revenue Next Year
- TPST N/A
- AIXI N/A
- P/E Ratio
- TPST N/A
- AIXI N/A
- Revenue Growth
- TPST N/A
- AIXI 18.84
- 52 Week Low
- TPST $5.35
- AIXI $1.29
- 52 Week High
- TPST $20.67
- AIXI $8.31
- Technical
- Relative Strength Index (RSI)
- TPST 63.44
- AIXI 48.36
- Support Level
- TPST $9.90
- AIXI $1.29
- Resistance Level
- TPST $11.18
- AIXI $1.92
- Average True Range (ATR)
- TPST 0.66
- AIXI 0.17
- MACD
- TPST -0.00
- AIXI 0.02
- Stochastic Oscillator
- TPST 80.69
- AIXI 48.18
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.